- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- The Top Science Progress Features of 2009
- Science Education Progress
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Neuroscience Everywhere
More research from neuroscientists on the devastating impact of poverty on childhood brain development. USA Today reports on a forthcoming study finding that “certain brain functions of some low-income 9- and 10-year-olds pale in comparison with those of wealthy children and that the difference is almost equivalent to the damage from a stroke.” University of Pennsylvania professor and Science Progress adviser Martha Farah is an author of the research.
In an interesting move, the Associated Press picked up the Commentary feature in this week’s online edition of Nature on healthy people enhancing their brain power with pharmaceuticals (which is presently available without a subscription). The authors (who again include Farah) “propose actions that will help society accept the benefits of enhancement, given appropriate research and evolved regulation.” They go on: “Prescription drugs are regulated as such not for their enhancing properties but primarily for considerations of safety and potential abuse. Still, cognitive enhancement has much to offer individuals and society, and a proper societal response will involve making enhancements available while managing their risks.”
Michael Rugnetta reported on the success of the first meeting of the Neuroethics Society in November, and AAAS, which hosted the event, now has full coverage posted. The focus is on military and national security applications of neuroscience, an issue Jonathan Moreno (who sat on a panel at the meeting) tackled in a recent feature, “Intelligence on the Brain.”
The most famous patient in neuroscience research, Henry Molaison–formerly known to only as H.M.–passed away last week. In order to treat debilitating seizures, he underwent surgery to remove the site of the problem, the hippocampus, and subsequently lost all ability to form new episodal memories. NYT has a full report, and ScienceBloggers Jake Young, Mo, and Omnibrain offer thoughtful reflections on the man who helped scientists understand how human memory works. (Hat tip to Alta Charo.)
Comments on this article
